Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O T Osman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Psychopharmacology Bulletin|January 1, 1992
Self-injurious behavior in the developmentally disabled: assessment techniquesE L Loschen, O T Osman
Biological Psychiatry|November 1, 1988
Neuroleptics and their metabolites binding to alpha 1 and D2 receptorsO T Osman, R E Becker
Psychopharmacology Bulletin|January 1, 1992
Self-injurious behavior in the developmentally disabled: pharmacologic treatmentO T Osman, E L Loschen
The American Journal of Psychiatry|July 1, 1989
Alprazolam and aggressionM V Rudorfer, O T Osman, W Z Potter
Psychopharmacology|January 1, 1993
Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humansO T Osman, J K Hsiao, W Z Potter
Archives of General Psychiatry|October 1, 1989
Idazoxan: a selective alpha 2-antagonist and effective sustained antidepressant in two bipolar depressed patientsO T Osman, M V Rudorfer, W Z Potter
Public Health|July 8, 2014
A call to address Dokha smoking: an emerging form of tobacco useR B Shaikh, J Muttappallymyalil, J Sreedharan, et al.
Clinical Pharmacology and Therapeutics|December 1, 1991
Pharmacokinetic and dynamic correlates of intravenous alprazolam challengeO T Osman, C L DeVane, D J Greenblatt, et al.
Biological Psychiatry|February 1, 1991
Hypothalamic--pituitary--adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapyM V Rudorfer, E D Risby, O T Osman, et al.
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
ECT treatment does not enhance neuroendocrine responses to serotonergic challengeH K Manji, J K Hsiao, E D Risby, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Psychopharmacology Bulletin|January 1, 1992
Self-injurious behavior in the developmentally disabled: assessment techniquesE L Loschen, O T Osman
Biological Psychiatry|November 1, 1988
Neuroleptics and their metabolites binding to alpha 1 and D2 receptorsO T Osman, R E Becker
Psychopharmacology Bulletin|January 1, 1992
Self-injurious behavior in the developmentally disabled: pharmacologic treatmentO T Osman, E L Loschen
The American Journal of Psychiatry|July 1, 1989
Alprazolam and aggressionM V Rudorfer, O T Osman, W Z Potter
Psychopharmacology|January 1, 1993
Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humansO T Osman, J K Hsiao, W Z Potter
Archives of General Psychiatry|October 1, 1989
Idazoxan: a selective alpha 2-antagonist and effective sustained antidepressant in two bipolar depressed patientsO T Osman, M V Rudorfer, W Z Potter
Public Health|July 8, 2014
A call to address Dokha smoking: an emerging form of tobacco useR B Shaikh, J Muttappallymyalil, J Sreedharan, et al.
Clinical Pharmacology and Therapeutics|December 1, 1991
Pharmacokinetic and dynamic correlates of intravenous alprazolam challengeO T Osman, C L DeVane, D J Greenblatt, et al.
Biological Psychiatry|February 1, 1991
Hypothalamic--pituitary--adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapyM V Rudorfer, E D Risby, O T Osman, et al.
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
ECT treatment does not enhance neuroendocrine responses to serotonergic challengeH K Manji, J K Hsiao, E D Risby, et al.
Pageof 2